Fox Run Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,630
Closed -$446K 1201
2025
Q3
$446K Buy
+1,630
New +$445K 0.07% 541
2025
Q1
Sell
-3,950
Closed -$903K 1177
2024
Q4
$903K Buy
+3,950
New +$951K 0.16% 194
2024
Q3
Sell
-8,347
Closed -$1.6M 1056
2024
Q2
$1.6M Buy
8,347
+4,408
+112% +$894K 0.3% 56
2024
Q1
$780K Buy
+3,939
New +$722K 0.17% 220
2023
Q3
Sell
-3,035
Closed -$663K 946
2023
Q2
$663K Buy
+3,035
New +$676K 0.19% 202
2023
Q1
Sell
-3,148
Closed -$655K 895
2022
Q4
$655K Buy
+3,148
New +$692K 0.26% 88
2022
Q1
Sell
-2,083
Closed -$543K 668
2021
Q4
$543K Buy
+2,083
New +$541K 0.32% 70
2021
Q1
Sell
-1,026
Closed -$218K 297
2020
Q4
$218K Buy
+1,026
New +$205K 0.44% 123
2018
Q3
Sell
-5,370
Closed -$556K 784
2018
Q2
$556K Buy
+5,370
New +$543K 0.18% 195
2017
Q4
Sell
-6,900
Closed -$531K 854
2017
Q3
$531K Buy
+6,900
New +$528K 0.15% 272
2017
Q2
Sell
-7,900
Closed -$569K 792
2017
Q1
$569K Buy
7,900
+1,300
+20% +$89.8K 0.23% 143
2016
Q4
$410K Buy
+6,600
New +$404K 0.22% 190

Other funds holding RMD

Fox Run Management's RMD Position: Q4 2025 in Review

Fox Run Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 1,630 shares — an estimated $446K sold.

Fox Run Management first reported a position in RMD in Q4 2016 and held it in 12 quarters. The position peaked at $1.6M in Q2 2024. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Fox Run Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 1,630 ResMed shares in Q4 2025, an estimated $446K.
  • Fox Run Management first reported a position in ResMed in Q4 2016 and held it in 12 quarters.
  • Fox Run Management's ResMed position peaked at $1.6M in Q2 2024.
  • 947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.